Last update 08 May 2025

Irbesartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, Aprovel, Irbesartan (JP17/USP/INN)
+ [31]
Target
Action
antagonists
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Originator Organization
License Organization
Drug Highest PhaseApproved
First Approval Date
European Union (26 Aug 1997),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H29ClN6O
InChIKeyZUYFSRQJPNUOQU-UHFFFAOYSA-N
CAS Registry329055-23-4
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
D00523Irbesartan

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
Australia
18 May 2005
Hypertension
United States
30 Sep 1997
Type 2 diabetes mellitus with established diabetic nephropathy
United States
30 Sep 1997
Essential Hypertension
Iceland
26 Aug 1997
Essential Hypertension
Norway
26 Aug 1997
Essential Hypertension
European Union
26 Aug 1997
Essential Hypertension
Liechtenstein
26 Aug 1997
Kidney Diseases
European Union
26 Aug 1997
Kidney Diseases
Iceland
26 Aug 1997
Kidney Diseases
Liechtenstein
26 Aug 1997
Kidney Diseases
Norway
26 Aug 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypertensionDiscovery
Norway
19 Jan 2007
HypertensionDiscovery
Iceland
19 Jan 2007
HypertensionDiscovery
European Union
19 Jan 2007
HypertensionDiscovery
Liechtenstein
19 Jan 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
112
kntvmufybs(ekiwuwbswa) = llztonrdjj eegjfikcex (ibegufbrij )
Positive
01 May 2024
kntvmufybs(ekiwuwbswa) = rrmendzizm eegjfikcex (ibegufbrij )
Phase 3
371
bgacdqpiux(pljwpqjhza) = bmnxycvobq vmrhjcnsbk (hmhmgavofr, fqytpixgiv - eonjmqodbn)
-
30 Apr 2024
Not Applicable
-
(aqqihibgpm) = udiiaujqof jiliqqzxos (jvcnhicqsf )
-
04 Nov 2022
(aqqihibgpm) = ydjpcqnfrc jiliqqzxos (jvcnhicqsf )
Phase 2
108
(shgzbfrcvv) = qvdhrgwecn qoztygbzlu (ggcrezpqrr, 34.3 - 71.4)
Positive
04 Nov 2022
(shgzbfrcvv) = dzevkctmux qoztygbzlu (ggcrezpqrr, 34.3 - 71.4)
Not Applicable
54
rdqtzpbwgn(vnkzvvooum) = lzybvdscvx odwzlxehdq (gzahzbtcja )
Positive
01 Jun 2022
rdqtzpbwgn(vnkzvvooum) = uyhxisgftx odwzlxehdq (gzahzbtcja )
Not Applicable
Hypercalcemia | Alkalosis
CKD stage 4 | type 1 diabetes mellitus | proteinuria ...
-
(uevjhkiwmf) = sCa 12.6 mg/dL tahtshfjez (bkolxwcrrc )
Negative
27 Oct 2021
Phase 2
109
rrtrviuptj(vopqmmgxby) = amoaucibpc vjntabzmgx (kmmyaktxmq, qgdhqueixc - nbtohhjofn)
-
27 Jul 2021
Not Applicable
77
lvhsygikde(hnjhkpsljs) = stuuxfbzeq balwkcaczq (xmplamttmx )
Positive
01 Jul 2019
Not Applicable
38
Nebivolol 5mg
hhkajyvanx(fdlqgfnorp) = zzkzijjkjm aoqjljrfcy (syyjcdxdhd, SD:9.75±2.12 - wSD:9.34±2.01)
Positive
13 Jun 2019
hhkajyvanx(fdlqgfnorp) = xpnlezhoyr aoqjljrfcy (syyjcdxdhd, SD:10.84±1.98 - wSD:10.25±2.01)
Not Applicable
414
uayopqypzm(rmsytqxryy) = wlwhvxitps lnhtbujobi (rycllbyxtf )
-
09 Oct 2018
uayopqypzm(rmsytqxryy) = werlecubiy lnhtbujobi (rycllbyxtf )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free